IntegraGen
OncoDNA to Widen Cancer Analytics Offering, Biopharma Reach With IntegraGen Acquisition
Belgium's OncoDNA believes that IntegraGen's bioinformatics platform will help it manage more cancer patient data and quickly generate patient-specific treatment reports for clinicians.
In Brief This Week: Biocartis, Celcuity, Immunovia, and More
Belgian MDx firm Biocartis said this week that it is adjusting its guidance for 2018, increasing its projection for new instrument placements and narrowing its expectation for cartridge volume.
In Brief This Week: Enzo Biochem, Personalis, MDxHealth, IntegraGen, and More
Enzo Biochem and its subsidiary Enzo Life Sciences announced this week that the Patent Trial and Appeal Board has denied a petition filed by Hologic for inter partes review, a procedure for challenging the validity of patent claims, against US Patent 6,221,581.
GoPath Labs to Commercialize IntegraGen Cancer Therapy Biomarker Test
GoPath has gained non-exclusive rights to commercialize a colorectal cancer test for the US and Canada based on IntegraGen's miR-31-3p biomarker.
IntegraGen Theranostic Test for Colorectal Cancer Gets CE-IVD Mark
The test, miRpredX 31-3p, is a positive theranostic test that quantifies the expression of miR-31-3p in FFPE using RT-qPCR technology.